Schiller Mark C. 4
4 · Kezar Life Sciences, Inc. · Filed Jan 13, 2025
Insider Transaction Report
Form 4
Schiller Mark C.
Chief Legal Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-01-09+24,500→ 24,500 totalExercise: $6.58Exp: 2035-01-08→ Common Stock (24,500 underlying)
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on February 9, 2025, subject to the Reporting Person continuing to provide service through each such date.